{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:31:25Z","timestamp":1785864685312,"version":"3.56.0"},"reference-count":58,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T00:00:00Z","timestamp":1478649600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T00:00:00Z","timestamp":1478649600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Mutation"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1002\/humu.23137","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T09:52:42Z","timestamp":1477043562000},"page":"226-235","source":"Crossref","is-referenced-by-count":61,"title":["Novel<i>BRCA1<\/i>and<i>BRCA2<\/i>Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas"],"prefix":"10.1155","volume":"38","author":[{"given":"Robbert D.A.","family":"Weren","sequence":"first","affiliation":[{"name":"Department of Human Genetics; Radboud University Medical Center; Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen R.","family":"Mensenkamp","sequence":"additional","affiliation":[{"name":"Department of Human Genetics; Radboud University Medical Center; Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Simons","sequence":"additional","affiliation":[{"name":"Department of Pathology; Radboud University Medical Center; Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Eijkelenboom","sequence":"additional","affiliation":[{"name":"Department of Pathology; Radboud University Medical Center; Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha S.","family":"Sie","sequence":"additional","affiliation":[{"name":"Department of Human Genetics; Radboud University Medical Center; Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"Ouchene","sequence":"additional","affiliation":[{"name":"Department of Human Genetics; Radboud University Medical Center; Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"van Asseldonk","sequence":"additional","affiliation":[{"name":"Department of Pathology; Radboud University Medical Center; Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Encarna B.","family":"Gomez-Garcia","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics; GROW - School for Oncology & Developmental Biology; Maastricht University Medical Centre; Maastricht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinus J.","family":"Blok","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics; GROW - School for Oncology & Developmental Biology; Maastricht University Medical Centre; Maastricht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne A.","family":"de Hullu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology; Radboud University Medical Center; Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel R.","family":"Nelen","sequence":"additional","affiliation":[{"name":"Department of Human Genetics; Radboud University Medical Center; Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hoischen","sequence":"additional","affiliation":[{"name":"Department of Human Genetics; Radboud University Medical Center; Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Bulten","sequence":"additional","affiliation":[{"name":"Department of Pathology; Radboud University Medical Center; Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan B.J.","family":"Tops","sequence":"additional","affiliation":[{"name":"Department of Pathology; Radboud University Medical Center; Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoline","family":"Hoogerbrugge","sequence":"additional","affiliation":[{"name":"Department of Human Genetics; Radboud University Medical Center; Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolijn J.L.","family":"Ligtenberg","sequence":"additional","affiliation":[{"name":"Department of Human Genetics; Radboud University Medical Center; Nijmegen The Netherlands"},{"name":"Department of Pathology; Radboud University Medical Center; Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,11,9]]},"reference":[{"key":"10.1002\/humu.23137-BIB0001|humu23137-cit-0001","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1002\/humu.23137-BIB0002|humu23137-cit-0002","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(10)60893-8","article-title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial","volume":"376","author":"Audeh","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/humu.23137-BIB0003|humu23137-cit-0003","first-page":"5329","article-title":"BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study","volume":"60","author":"Baldwin","year":"2000","journal-title":"Cancer Res"},{"key":"10.1002\/humu.23137-BIB0004|humu23137-cit-0004","first-page":"2433","article-title":"Frequency of germline and somatic BRCA1 mutations in ovarian cancer","volume":"4","author":"Berchuck","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1002\/humu.23137-BIB0005|humu23137-cit-0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/carcin\/21.2.147","article-title":"Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer","volume":"21","author":"Bianco","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1002\/humu.23137-BIB0006|humu23137-cit-0006","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","article-title":"Clinicopathologic features of BRCA-linked and sporadic ovarian cancer","volume":"283","author":"Boyd","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/humu.23137-BIB0007|humu23137-cit-0007","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/bioinformatics\/btu353","article-title":"MIPgen: optimized modeling and design of molecular inversion probes for targeted resequencing","volume":"30","author":"Boyle","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1002\/humu.23137-BIB0008|humu23137-cit-0008","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"key":"10.1002\/humu.23137-BIB0009|humu23137-cit-0009","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research","year":"2011","journal-title":"Nature"},{"key":"10.1002\/humu.23137-BIB0010|humu23137-cit-0010","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40291-014-0115-2","article-title":"Cytosine deamination is a major cause of baseline noise in next-generation sequencing","volume":"18","author":"Chen","year":"2014","journal-title":"Mol Diagn Ther"},{"key":"10.1002\/humu.23137-BIB0011|humu23137-cit-0011","doi-asserted-by":"crossref","first-page":"562","DOI":"10.6004\/jnccn.2010.0043","article-title":"Genetic\/familial high-risk assessment: breast and ovarian","volume":"8","author":"Daly","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1002\/humu.23137-BIB0012|humu23137-cit-0012","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cca.2015.03.045","article-title":"The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches","volume":"446","author":"D'Argenio","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1002\/humu.23137-BIB0013|humu23137-cit-0013","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study","volume":"15","author":"Angelis","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1002\/humu.23137-BIB0014|humu23137-cit-0014","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10689-009-9240-1","article-title":"Methylation not a frequent \"second hit\" in tumors with germline BRCA mutations","volume":"8","author":"Dworkin","year":"2009","journal-title":"Fam Cancer"},{"key":"10.1002\/humu.23137-BIB0015|humu23137-cit-0015","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jmoldx.2016.06.010","article-title":"Reliable next generation sequencing of FFPE tissue using single molecule tags","volume":"18","author":"Eijkelenboom","year":"2016","journal-title":"J Mol Diagn"},{"key":"10.1002\/humu.23137-BIB0016|humu23137-cit-0016","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12907-015-0004-6","article-title":"A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing","volume":"15","author":"Ellison","year":"2015","journal-title":"BMC Clin Pathol"},{"key":"10.1002\/humu.23137-BIB0017|humu23137-cit-0017","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","article-title":"Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors","volume":"92","author":"Esteller","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/humu.23137-BIB0018|humu23137-cit-0018","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1002\/humu.23137-BIB0019|humu23137-cit-0019","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ejhg.2012.270","article-title":"Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes","volume":"21","author":"Feliubadalo","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1002\/humu.23137-BIB0020|humu23137-cit-0020","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1002\/humu.23137-BIB0021|humu23137-cit-0021","first-page":"3622","article-title":"Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer","volume":"56","author":"Foster","year":"1996","journal-title":"Cancer Res"},{"key":"10.1002\/humu.23137-BIB0022|humu23137-cit-0022","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1200\/JCO.2009.27.2997","article-title":"Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer","volume":"28","author":"Hennessy","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1002\/humu.23137-BIB0023|humu23137-cit-0023","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1101\/gr.147686.112","article-title":"Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation","volume":"23","author":"Hiatt","year":"2013","journal-title":"Genome Res"},{"key":"10.1002\/humu.23137-BIB0024|humu23137-cit-0024","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mgg3.120","article-title":"Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next-generation sequencing","volume":"3","author":"Hirotsu","year":"2015","journal-title":"Mol Genet Genomic Med"},{"key":"10.1002\/humu.23137-BIB0025|humu23137-cit-0025","doi-asserted-by":"crossref","first-page":"20166","DOI":"10.1073\/pnas.1110064108","article-title":"Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID","volume":"108","author":"Jabara","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.23137-BIB0026|humu23137-cit-0026","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1038\/ncomms4156","article-title":"Integrated analysis of germline and somatic variants in ovarian cancer","volume":"5","author":"Kanchi","year":"2014","journal-title":"Nat Commun"},{"key":"10.1002\/humu.23137-BIB0027|humu23137-cit-0027","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s13059-014-0530-z","article-title":"Deep sequencing of multiple regions of glial tumors reveals spatial heterogeneity for mutations in clinically relevant genes","volume":"15","author":"Kumar","year":"2014","journal-title":"Genome Biol"},{"key":"10.1002\/humu.23137-BIB0028|humu23137-cit-0028","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1002\/humu.23137-BIB0029|humu23137-cit-0029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1002\/humu.23137-BIB0030|humu23137-cit-0030","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1470-2045(14)70228-1","article-title":"Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial","volume":"15","author":"Ledermann","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1002\/humu.23137-BIB0031|humu23137-cit-0031","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/25292","article-title":"Genetic instabilities in human cancers","volume":"396","author":"Lengauer","year":"1998","journal-title":"Nature"},{"key":"10.1002\/humu.23137-BIB0032|humu23137-cit-0032","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S1470-2045(14)70391-2","article-title":"Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study","volume":"15","author":"Liu","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1002\/humu.23137-BIB0033|humu23137-cit-0033","doi-asserted-by":"crossref","first-page":"19872","DOI":"10.1073\/pnas.1319590110","article-title":"High-throughput DNA sequencing errors are reduced by orders of magnitude using circle sequencing","volume":"110","author":"Lou","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.23137-BIB0034|humu23137-cit-0034","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2013.03.026","article-title":"An international assessment of ovarian cancer incidence and mortality","volume":"130","author":"Lowe","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1002\/humu.23137-BIB0035|humu23137-cit-0035","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.18632\/oncotarget.6834","article-title":"BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing","volume":"7","author":"Mafficini","year":"2016","journal-title":"Oncotarget"},{"key":"10.1002\/humu.23137-BIB0036|humu23137-cit-0036","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","article-title":"DNA-repair defects and olaparib in metastatic prostate cancer","volume":"373","author":"Mateo","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1002\/humu.23137-BIB0037|humu23137-cit-0037","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/nar\/gkj518","article-title":"Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods","volume":"34","author":"Mathe","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1002\/humu.23137-BIB0038|humu23137-cit-0038","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","article-title":"Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition","volume":"66","author":"McCabe","year":"2006","journal-title":"Cancer Res"},{"key":"10.1002\/humu.23137-BIB0039|humu23137-cit-0039","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/ng0495-439","article-title":"Somatic mutations in the BRCA1 gene in sporadic ovarian tumours","volume":"9","author":"Merajver","year":"1995","journal-title":"Nat Genet"},{"key":"10.1002\/humu.23137-BIB0040|humu23137-cit-0040","article-title":"BRCA testing by single molecule molecular inversion probes","author":"Neveling","journal-title":"Clin Chem"},{"key":"10.1002\/humu.23137-BIB0041|humu23137-cit-0041","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2010.34.2980","article-title":"Secondary somatic mutations restoring BRCA1\/2 predict chemotherapy resistance in hereditary ovarian carcinomas","volume":"29","author":"Norquist","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1002\/humu.23137-BIB0042|humu23137-cit-0042","unstructured":"Oncoline 2015 Oncoline richtlijnen oncologische zorg http:\/\/www.oncoline.nl\/erfelijk-en-familiair-ovariumcarcinoom"},{"key":"10.1002\/humu.23137-BIB0043|humu23137-cit-0043","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1126\/science.1227764","article-title":"Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders","volume":"338","author":"O'Roak","year":"2012","journal-title":"Science"},{"key":"10.1002\/humu.23137-BIB0044|humu23137-cit-0044","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1470-2045(14)71135-0","article-title":"Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial","volume":"16","author":"Oza","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1002\/humu.23137-BIB0045|humu23137-cit-0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature14410","article-title":"Whole-genome characterization of chemoresistant ovarian cancer","volume":"521","author":"Patch","year":"2015","journal-title":"Nature"},{"key":"10.1002\/humu.23137-BIB0046|humu23137-cit-0046","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1101\/gr.097857.109","article-title":"Detection of nonneutral substitution rates on mammalian phylogenies","volume":"20","author":"Pollard","year":"2010","journal-title":"Genome Res"},{"key":"10.1002\/humu.23137-BIB0047|humu23137-cit-0047","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.humpath.2005.06.006","article-title":"Hereditary ovarian cancer","volume":"36","author":"Prat","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1002\/humu.23137-BIB0048|humu23137-cit-0048","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S1470-2045(13)70240-7","article-title":"The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial","volume":"14","author":"Sandhu","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1002\/humu.23137-BIB0049|humu23137-cit-0049","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.4161\/epi.22561","article-title":"BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer","volume":"7","author":"Stefansson","year":"2012","journal-title":"Epigenetics"},{"key":"10.1002\/humu.23137-BIB0050|humu23137-cit-0050","doi-asserted-by":"crossref","first-page":"e0136419","DOI":"10.1371\/journal.pone.0136419","article-title":"Development and validation of a next-generation sequencing assay for BRCA1 and BRCA2 variants for the clinical laboratory","volume":"10","author":"Strom","year":"2015","journal-title":"PLoS One"},{"key":"10.1002\/humu.23137-BIB0051|humu23137-cit-0051","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jmg.2005.033878","article-title":"Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral","volume":"43","author":"Tavtigian","year":"2006","journal-title":"J Med Genet"},{"key":"10.1002\/humu.23137-BIB0052|humu23137-cit-0052","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jmoldx.2014.11.004","article-title":"Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and\/or ovarian cancer","volume":"17","author":"Trujillano","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1002\/humu.23137-BIB0053|humu23137-cit-0053","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1200\/JCO.2010.30.1010","article-title":"BRCA1 CpG island hypermethylation predicts sensitivity to poly(adenosine diphosphate)-ribose polymerase inhibitors","volume":"28","author":"Veeck","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1002\/humu.23137-BIB0054|humu23137-cit-0054","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/humu.22253","article-title":"Guidelines for reporting and using prediction tools for genetic variation analysis","volume":"34","author":"Vihinen","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.23137-BIB0055|humu23137-cit-0055","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/PPO.0b013e31826246c2","article-title":"Genetic testing by cancer site: ovary","volume":"18","author":"Weissman","year":"2012","journal-title":"Cancer J"},{"key":"10.1002\/humu.23137-BIB0056|humu23137-cit-0056","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.3287","article-title":"A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer","volume":"47","author":"Weren","year":"2015","journal-title":"Nat Genet"},{"key":"10.1002\/humu.23137-BIB0057|humu23137-cit-0057","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1755-8794-7-23","article-title":"Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing","volume":"7","author":"Wong","year":"2014","journal-title":"BMC Med Genomics"},{"key":"10.1002\/humu.23137-BIB0058|humu23137-cit-0058","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/cncr.2820710205","article-title":"Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality","volume":"71","author":"Yancik","year":"1993","journal-title":"Cancer"}],"container-title":["Human Mutation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhumu.23137","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/humu.23137\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T16:54:59Z","timestamp":1672332899000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/humu.23137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,9]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"URL":"https:\/\/doi.org\/10.1002\/humu.23137","archive":["Portico"],"relation":{},"ISSN":["1059-7794"],"issn-type":[{"value":"1059-7794","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11,9]]}}}